These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 987966)

  • 21. [Effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil) on the cardiovascular system in vivo].
    Mizusawa H; Sakakibara E
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):597-608. PubMed ID: 1238330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of methyl O-(4-hydroxy-3-methoxycinnamoly)reserpate (CD-3400) on the peripheral nervous system: especially on the smooth muscle organs].
    Miyake N; Hasegawa Y; Tamada T; Fujimoto Y
    Nihon Yakurigaku Zasshi; 1976 Nov; 72(8):991-1000. PubMed ID: 14872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Omori M; Muroda T; Nakajima S; Nakada Y; Tanada K; Senda N; Tanaka K; Makino H
    Jpn J Antibiot; 1980 Oct; 33(10):994-1018. PubMed ID: 6451724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-piperidino-3-(4'-octylphenyl)-propane-3-one-hydrochloride, a new peripheral and coronary vasodilator.
    Kárpáti E; Dömök L; Szporny L
    Arzneimittelforschung; 1969 Jun; 19(6):1011-5. PubMed ID: 4389902
    [No Abstract]   [Full Text] [Related]  

  • 25. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phamacolofical studies of ifenprodil].
    Maeda Y; Furukawa T
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):585-95. PubMed ID: 1238329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [General pharmacological studies on pepleomycin sulfate (NK 631) (author's transl)].
    Ishii Y; Furuta Y; Adachi K; Fujii Y; Nakamura K; Itoh S; Saitoh K; Terada M; Watanabe H
    Jpn J Antibiot; 1978 Dec; 31(12):910-21. PubMed ID: 83413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
    Goto K; Osuga K; Haga K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). III. Effect on smooth-muscle organs (author's transl)].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Omori M
    Jpn J Antibiot; 1977 Aug; 30(8):557-70. PubMed ID: 909144
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of the new beta-adrenoceptor blocking agent, S-596 on the peripheral autonomic nervous system and smooth muscles.
    Miyagishi A; Nakahara H; Hara Y; Nakatani H
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):222-37. PubMed ID: 6188420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 9 - and 8 -tetrahydrocannabinol on the peripheral autonomic nervous system in vitro.
    Gascon AL; Pérès MT
    Can J Physiol Pharmacol; 1973 Jan; 51(1):12-21. PubMed ID: 4348120
    [No Abstract]   [Full Text] [Related]  

  • 38. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological studies on basic ethers (R111 and R97) with antispasmodic activity].
    Matsuda H; Kato T; Yamamoto Y; Miichi H; Ogawa S
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):381-95. PubMed ID: 987972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [General pharmacology of BMY-28100].
    Goto A; Amano M; Sakai A; Hara M; Takahashi N
    Jpn J Antibiot; 1990 Jul; 43(7):1289-309. PubMed ID: 2232158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.